 
        
        
      
    
    Sponsors
Trusted partnerships for over 35 years.
Since 1988, as a private, clinical trial site, MICR ® has participated in over 550 clinical trials spanning a wide range of medications for a variety of cardio-metabolic diseases. These Phase II/III trials have been with major pharmaceutical companies such as:
All trademarks, logos, and brand names are the property of their respective owners and are used here for identification purposes only.
- 
      
        
          
        
      
      ● All Antihypertensive classes 
 ● Efficacy, Quality-of-Life, ABPM
- 
      
        
      
      ● Hyperlipidemia ● Diabetes (Type II) ● Osteoporosis 
- 
      
        
      
      ● GLP-1 receptor agonists ● Lipase inhibitors 
- 
      
        
      
      ● NSAID-Induced Gastritis ● Heartburn (RX-OTC) ● DU/GU ● GERD 
- 
      
        
      
      ● Osteoarthritis 
- 
      
        
      
      ● Tension ● Migraine 
- 
      
        
      
      ● Pain ● Cough/Cold ● Taste Testing 
- 
      
        
      
      ● Finger stick 
What distinguishes MICR®?
MICR® is dedicated to provide the highest quality service to the pharmaceutical and medical device industry as well as to the volunteers who participate in these clinical trials from the recruitment stage through the completion of the study. We consistently provide:
Our onsite and experienced physicians.
Serving as the Principal Investigator and/or sub-investigator for all protocols. One or more of the physicians are always onsite during regular business hours to implement protocols, interface with sponsors, and oversee patient safety for all ongoing research studies.
Our experienced, full-time staff.
Study coordinators, coordinator associates, and nurse practitioners that provide participants a seamless and rewarding experience.
Our shared commitment to success.
MICR® consistently delivers high-quality trial implementation and the highest level of personalized care to those individuals participating in the trial.
 
                        